Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

INDUSTRY 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 1

Interventions

Cyclophosphamide 15 Vincristine 13 Prednisone 13 Rituximab 12 Doxorubicin 11 Etoposide 10 Radiotherapy 9 Methotrexate 6 Filgrastim 6 Cytarabine 6 Gemcitabine 5 Cisplatin 5 VAP-cyclo protocol 4 Granulocyte Colony-Stimulating Factor 4 ibritumomab tiuxetan 3 Peripheral Blood Stem Cell Transplantation 3 Methylprednisolone 3 Leucovorin 3 Immunohistochemistry 3 Ifosfamide 3 Gene Expression Profiling 3 Dexamethasone 3 pegfilgrastim 2 merphos 2 fludarabine 2 axicabtagene ciloleucel 2 Watchful Waiting 2 Specimen Handling 2 Mesna 2 Magnetic Resonance Spectroscopy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Lymphoma, Large B-Cell, Diffuse × idelalisib × Clear all

NCT03576443 2021-10-13

ILIAD

Nordic Lymphoma Group

Phase 2 Completed

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡